Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease
- PMID: 8370580
- DOI: 10.1007/BF00219682
Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease
Abstract
Sphingolipid activator protein (SAP) deficiency, previously described in two sibs and shown to be caused by the absence of the common saposin precursor (prosaposin), was further characterized by biochemical lipid and enzyme studies and by ultrastructural analysis. The 20-week-old fetal sib had increased concentrations of neutral glycolipids, including mono-, di-, tri- and tetrahexosylceramide, in liver, kidney and cultured skin fibroblasts compared with the controls. Glucosylceramide and lactosylceramide were particularly elevated. The kidney of the affected fetus showed additional increases in the concentration of sulphatide, galactosylceramide and digalactosylceramide. Free ceramide was stored in the liver and kidney, and GM3 and GM2 gangliosides were elevated in the liver, but not the brain, of the fetus. Phospholipids, however, were normal in the affected fetus. In the liver biopsy of the propositus, who later died at 16 weeks of age, only a few lipids could be studied. Glucosylceramide, dihexosylceramide and ceramide were elevated in agreement with our previous study. Enzyme studies were undertaken using detergent-free liposomal substrate preparations and fibroblast extracts. The sibs' beta-glucocerebrosidase and beta-galactocerebrosidase activities were clearly reduced, but their sphingomyelinase activities were normal. The normal activity of the latter enzyme and the almost normal tissue concentration of sphingomyelin in prosaposin deficiency suggest that the prosaposin-derived SAPs are not required for sphingomyelinase activity in vivo. In keeping with the biochemical findings, skin biopsies from the sibs showed massive lysosomal storage with a vesicular and membranous ultrastructure. The function of SAPs in sphingolipid degradation and the role of SAPs for enzyme activity in vitro are discussed. In addition, the similarity in neutral glycolipid accumulations in Niemann-Pick disease type C and in prosaposin deficiency are noted. The phenotype of the prosaposin deficient sibs resembled acute neuronopathic (type 2) Gaucher disease more than Farber disease in several aspects, but their genotype was unique.
Similar articles
-
A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation.Hum Mol Genet. 2001 Apr 15;10(9):927-40. doi: 10.1093/hmg/10.9.927. Hum Mol Genet. 2001. PMID: 11309366
-
Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.Hum Genet. 1992 Jul;89(5):513-8. doi: 10.1007/BF00219176. Hum Genet. 1992. PMID: 1634229
-
Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.Biochem J. 1992 Jul 15;285 ( Pt 2)(Pt 2):481-8. doi: 10.1042/bj2850481. Biochem J. 1992. PMID: 1637339 Free PMC article.
-
Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses.Eur J Pediatr. 1989 Oct;149(1):31-9. doi: 10.1007/BF02024331. Eur J Pediatr. 1989. PMID: 2514102 Review.
-
Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature.Neurochem Res. 1999 Apr;24(4):481-9. doi: 10.1023/a:1022575511354. Neurochem Res. 1999. PMID: 10227680 Review.
Cited by
-
Identification of dysregulation of sphingolipids in retinoblastoma using liquid chromatography-mass spectrometry.Exp Eye Res. 2024 Mar;240:109798. doi: 10.1016/j.exer.2024.109798. Epub 2024 Jan 19. Exp Eye Res. 2024. PMID: 38246332 Free PMC article.
-
Neurotoxic stimulation alters prosaposin levels in the salivary systems of rats.Cell Tissue Res. 2024 Feb;395(2):159-169. doi: 10.1007/s00441-023-03847-6. Epub 2023 Dec 12. Cell Tissue Res. 2024. PMID: 38082139
-
Lysosomal storage disorders: molecular basis and laboratory testing.Hum Genomics. 2011 Mar;5(3):156-69. doi: 10.1186/1479-7364-5-3-156. Hum Genomics. 2011. PMID: 21504867 Free PMC article. Review.
-
Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations.Am J Med Genet A. 2009 Feb 15;149A(4):613-21. doi: 10.1002/ajmg.a.32712. Am J Med Genet A. 2009. PMID: 19267410 Free PMC article.
-
Ceramide accumulation is associated with increased apoptotic cell death in cultured fibroblasts of sphingolipid activator protein-deficient mouse but not in fibroblasts of patients with Farber disease.J Inherit Metab Dis. 1999 Jun;22(5):649-62. doi: 10.1023/a:1005590316064. J Inherit Metab Dis. 1999. PMID: 10399097
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Miscellaneous